Pages that link to "Q41862250"
Jump to navigation
Jump to search
The following pages link to Interleukin-1 promotes expression and phosphorylation of neurofilament and tau proteins in vivo (Q41862250):
Displaying 50 items.
- Dementia with Lewy bodies: Definition, diagnosis, and pathogenic relationship to Alzheimer's disease (Q24657382) (← links)
- Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease (Q26799870) (← links)
- Neuroinflammation in Alzheimer's disease: chemokines produced by astrocytes and chemokine receptors (Q26995483) (← links)
- Age-dependent neuroinflammation and cognitive decline in a novel Ala152Thr-Tau transgenic mouse model of PSP and AD. (Q27317039) (← links)
- Interleukin-1β protects astrocytes against oxidant-induced injury via an NF-κB-dependent upregulation of glutathione synthesis. (Q27335319) (← links)
- Inflammatory process in Alzheimer's Disease (Q27500412) (← links)
- Interleukin-1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer's disease (Q28216434) (← links)
- Interactions between inflammation, sex steroids, and Alzheimer's disease risk factors (Q28394967) (← links)
- Interleukin-1beta enhances nucleotide-induced and alpha-secretase-dependent amyloid precursor protein processing in rat primary cortical neurons via up-regulation of the P2Y(2) receptor (Q28574838) (← links)
- R-flurbiprofen improves tau, but not Aß pathology in a triple transgenic model of Alzheimer's disease (Q30684317) (← links)
- LW-AFC, a new formula derived from Liuwei Dihuang decoction, ameliorates behavioral and pathological deterioration via modulating the neuroendocrine-immune system in PrP-hAβPPswe/PS1ΔE9 transgenic mice. (Q30831806) (← links)
- The role of biomarkers in clinical trials for Alzheimer disease (Q31032781) (← links)
- Blocking IL-1 signaling rescues cognition, attenuates tau pathology, and restores neuronal β-catenin pathway function in an Alzheimer's disease model (Q33810933) (← links)
- Interleukin-1 and the immunogenetics of Alzheimer disease (Q33941294) (← links)
- The pervasiveness of interleukin-1 in alzheimer pathogenesis: a role for specific polymorphisms in disease risk (Q34013763) (← links)
- Interleukin-1 beta exerts a myriad of effects in the brain and in particular in the hippocampus: analysis of some of these actions. (Q34566251) (← links)
- Neuroinflammation and anti-inflammatory therapy for Alzheimer's disease (Q35009772) (← links)
- Presence of reactive microglia and neuroinflammatory mediators in a case of frontotemporal dementia with P301S mutation (Q35546446) (← links)
- Interleukin-1β in Central Nervous System Injury and Repair. (Q35737149) (← links)
- Neuroinflammatory Cytokines-The Common Thread in Alzheimer's Pathogenesis (Q35815212) (← links)
- Trisomy 21 and the brain (Q35854503) (← links)
- Basal forebrain cholinergic dysfunction in Alzheimer's disease--interrelationship with beta-amyloid, inflammation and neurotrophin signaling (Q36269317) (← links)
- Transcriptional alterations related to neuropathology and clinical manifestation of Alzheimer's disease. (Q36381106) (← links)
- Current strategies for the treatment of Alzheimer's disease and other tauopathies (Q36596669) (← links)
- Sustained interleukin-1β overexpression exacerbates tau pathology despite reduced amyloid burden in an Alzheimer's mouse model (Q36799810) (← links)
- Ibuprofen reduces Abeta, hyperphosphorylated tau and memory deficits in Alzheimer mice (Q36983713) (← links)
- Inflammation and clinical presentation in neurodegenerative disease: a volatile relationship (Q37069901) (← links)
- The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective (Q37095615) (← links)
- Down's syndrome, neuroinflammation, and Alzheimer neuropathogenesis (Q37113208) (← links)
- The comorbidity of HIV-associated neurocognitive disorders and Alzheimer's disease: a foreseeable medical challenge in post-HAART era (Q37193610) (← links)
- Clearance mechanisms of Alzheimer's amyloid-beta peptide: implications for therapeutic design and diagnostic tests. (Q37270464) (← links)
- Interleukin-1 promotion of MAPK-p38 overexpression in experimental animals and in Alzheimer's disease: potential significance for tau protein phosphorylation (Q37324225) (← links)
- T Lymphocytes and Inflammatory Mediators in the Interplay between Brain and Blood in Alzheimer's Disease: Potential Pools of New Biomarkers (Q37672845) (← links)
- Neuroinflammatory processes in Alzheimer's disease (Q37772809) (← links)
- Emerging roles of pathogens in Alzheimer disease (Q37935917) (← links)
- Association between interleukin-1α C(-889)T polymorphism and Alzheimer's disease: a meta-analysis including 12,817 subjects (Q38074322) (← links)
- Shared Genetic Risk Factors for Late-Life Depression and Alzheimer's Disease (Q38802908) (← links)
- Inflammatory Cytokines and Alzheimer's Disease: A Review from the Perspective of Genetic Polymorphisms (Q38938968) (← links)
- The Role of Microglia in the Etiology and Evolution of Chronic Traumatic Encephalopathy. (Q39149587) (← links)
- Impact of Cytokines and Chemokines on Alzheimer's Disease Neuropathological Hallmarks (Q39186980) (← links)
- A novel p38 alpha MAPK inhibitor suppresses brain proinflammatory cytokine up-regulation and attenuates synaptic dysfunction and behavioral deficits in an Alzheimer's disease mouse model. (Q40177595) (← links)
- Importance of MAPK pathways for microglial pro-inflammatory cytokine IL-1 beta production (Q40580069) (← links)
- IFN-γ promotes τ phosphorylation without affecting mature tangles (Q40757303) (← links)
- Brain omega-3 polyunsaturated fatty acids modulate microglia cell number and morphology in response to intracerebroventricular amyloid-β 1-40 in mice. (Q41217789) (← links)
- A beneficial role for IL-1 beta in Alzheimer disease? (Q42058841) (← links)
- Degeneration of beta-amyloid-associated cholinergic structures in transgenic APP SW mice. (Q44466824) (← links)
- Interleukin-1beta up-regulates expression of neurofilament light in human neuronal cells (Q46683939) (← links)
- Pharmacological targeting of GSK-3 and NRF2 provides neuroprotection in a preclinical model of tauopathy (Q47113551) (← links)
- COX-2 metabolic products, the prostaglandin I2 and F2α, mediate the effects of TNF-α and Zn2+ in stimulating the phosphorylation of Tau. (Q47160386) (← links)
- Rheumatic diseases are associated with a higher risk of dementia: A nation-wide, population-based, case-control study (Q47305410) (← links)